Neoantigens are a series of immunogenic peptides produced by tumor-specific mutations, which can be used as biomarkers to distinguish cancer cells from normal cells. Since neoantigens are specifically expressed in tumor cells, their induction tolerance is low and they are safe targets when used in tumor immunotherapy.